BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Boston
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201202T070000
DTEND;TZID=America/Vancouver:20201204T160000
DTSTAMP:20260413T020738
CREATED:20201123T215713Z
LAST-MODIFIED:20201123T215713Z
UID:11817-1606892400-1607097600@scienceinboston.com
SUMMARY:2020 HMS Research Cores Online Poster Showcase
DESCRIPTION:Research Cores provide specialized services\, equipment\, and staff. Attend this event to learn about core technologies and resources at HMS.\n\n\n\n\n\nAbout this Event\n\n\nNote: Registration will remain open through noon on Dec. 4th. Register any time to attend the event. \nPoster Gallery opens Wednesday\, Dec. 2nd \nZoom meetings with Research Core Presenters: \nDecember 3rd\, 2020 \n10:30 – 11:30am ET \n12:30 – 1:30pm ET \n2:30 – 3:30pm ET \nDecember 4th\, 2020 \n10:30 – 11:30am ET \nFor the general schedule\, please visit the HMS cores website: https://corefacilities.hms.harvard.edu \nDetailed Zoom schedule information and meeting links will be emailed to registered Poster Showcase attendees.
URL:https://scienceinboston.com/event/2020-hms-research-cores-online-poster-showcase/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201202T070000
DTEND;TZID=America/Vancouver:20201204T160000
DTSTAMP:20260413T020738
CREATED:20201123T215713Z
LAST-MODIFIED:20201123T215713Z
UID:27610-1606892400-1607097600@scienceinboston.com
SUMMARY:2020 HMS Research Cores Online Poster Showcase
DESCRIPTION:Research Cores provide specialized services\, equipment\, and staff. Attend this event to learn about core technologies and resources at HMS.\n\n\n\n\n\nAbout this Event\n\n\nNote: Registration will remain open through noon on Dec. 4th. Register any time to attend the event. \nPoster Gallery opens Wednesday\, Dec. 2nd \nZoom meetings with Research Core Presenters: \nDecember 3rd\, 2020 \n10:30 – 11:30am ET \n12:30 – 1:30pm ET \n2:30 – 3:30pm ET \nDecember 4th\, 2020 \n10:30 – 11:30am ET \nFor the general schedule\, please visit the HMS cores website: https://corefacilities.hms.harvard.edu \nDetailed Zoom schedule information and meeting links will be emailed to registered Poster Showcase attendees.
URL:https://scienceinboston.com/event/2020-hms-research-cores-online-poster-showcase-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201201T160000
DTEND;TZID=America/Vancouver:20201201T170000
DTSTAMP:20260413T020738
CREATED:20201123T220936Z
LAST-MODIFIED:20201123T220950Z
UID:11823-1606838400-1606842000@scienceinboston.com
SUMMARY:MIT Biology Colloquium Series: Dr. Erin Schuman
DESCRIPTION:Speaker: Dr. Erin Schuman\, Max-Planck Institute. Title:” Neuronal Logistics: Transcriptomes\, Translatomes and Proteomes.”  Hosted by Elly Nedivi. The Biology Colloquium is a weekly seminar held throughout the academic year\, featuring distinguished speakers in many areas of the biological sciences\, from universities and institutions worldwide. More information on speakers\, their affiliations\, and titles of their talks will be added as available. The Colloquium will zoom at 4:00PM  Tuesdays during the school year. Contact: Linda Earle lkn@mit.edu
URL:https://scienceinboston.com/event/biology-colloquium-series-dr-erin-schuman/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201201T160000
DTEND;TZID=America/Vancouver:20201201T170000
DTSTAMP:20260413T020738
CREATED:20201123T220936Z
LAST-MODIFIED:20201123T220936Z
UID:27612-1606838400-1606842000@scienceinboston.com
SUMMARY:MIT Biology Colloquium Series: Dr. Erin Schuman
DESCRIPTION:Speaker: Dr. Erin Schuman\, Max-Planck Institute. Title:” Neuronal Logistics: Transcriptomes\, Translatomes and Proteomes.”  Hosted by Elly Nedivi. The Biology Colloquium is a weekly seminar held throughout the academic year\, featuring distinguished speakers in many areas of the biological sciences\, from universities and institutions worldwide. More information on speakers\, their affiliations\, and titles of their talks will be added as available. The Colloquium will zoom at 4:00PM  Tuesdays during the school year. Contact: Linda Earle lkn@mit.edu
URL:https://scienceinboston.com/event/biology-colloquium-series-dr-erin-schuman-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201201T110000
DTEND;TZID=America/Vancouver:20201201T113000
DTSTAMP:20260413T020738
CREATED:20201124T190122Z
LAST-MODIFIED:20201124T190122Z
UID:11854-1606820400-1606822200@scienceinboston.com
SUMMARY:MassBio Town Hall - 2021 Biotech Outlook
DESCRIPTION:MassBio’s President & CEO\, Bob Coughlin\, will host a regular virtual Town Hall for members. This will be an opportunity for our members to ask questions\, hear what MassBio is up to\, and learn more about the state of the industry amidst the COVID-19 pandemic. \nThis Town Hall will feature Matthew Harrison\, a Managing Director and Head of Biotech Industry Research at Morgan Stanley\, who will share predictions for the biotech outlook in 2021. \nWebinar link will be emailed to participants the day before – you can also access it from the “Live Stream” tab below. \nMassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations\, such as captioning.
URL:https://scienceinboston.com/event/massbio-town-hall-2021-biotech-outlook/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201201T110000
DTEND;TZID=America/Vancouver:20201201T113000
DTSTAMP:20260413T020738
CREATED:20201124T190122Z
LAST-MODIFIED:20201124T190122Z
UID:27618-1606820400-1606822200@scienceinboston.com
SUMMARY:MassBio Town Hall - 2021 Biotech Outlook
DESCRIPTION:MassBio’s President & CEO\, Bob Coughlin\, will host a regular virtual Town Hall for members. This will be an opportunity for our members to ask questions\, hear what MassBio is up to\, and learn more about the state of the industry amidst the COVID-19 pandemic. \nThis Town Hall will feature Matthew Harrison\, a Managing Director and Head of Biotech Industry Research at Morgan Stanley\, who will share predictions for the biotech outlook in 2021. \nWebinar link will be emailed to participants the day before – you can also access it from the “Live Stream” tab below. \nMassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations\, such as captioning.
URL:https://scienceinboston.com/event/massbio-town-hall-2021-biotech-outlook-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201119T120000
DTEND;TZID=America/Vancouver:20201119T130000
DTSTAMP:20260413T020738
CREATED:20201103T214500Z
LAST-MODIFIED:20201103T214500Z
UID:11466-1605787200-1605790800@scienceinboston.com
SUMMARY:Dana Farber Targeted Protein Degradation Seminar: Dan Nomura
DESCRIPTION:Reimagining Druggability using Chemoproteomic Platforms\nWebinar registration: \nhttps://dfci.zoom.us/webinar/register/WN_IgnG5R2VSseCnikqf-v_1A \nHost: Breanna Zerfas \n\n\nDan Nomura\n\n\nDan Nomura is a professor in the Departments of Chemistry\, Molecular and Cell Biology\, and Nutritional Sciences and Toxicology at the University of California\, Berkeley. He is the director of the Novartis-Berkeley Center for Proteomics and Chemistry Technologies focused on using chemoproteomic platforms to tackle the undruggable proteome. Dr. Nomura is also the co-founder for Frontier Medicines. Dr. Nomura is an editor for Cell Chemical Biology. He earned his B.A. in Molecular and Cell Biology and Ph.D. in Molecular Toxicology with Professor John Casida at UC Berkeley and was a postdoctoral fellow at The Scripps Research Institute in chemical physiology with Professor Ben Cravatt before returning to UC Berkeley as a faculty member in 2011. Among his honors are selection as a Searle Scholar\, American Cancer Society Research Scholar Award\, and the Mark Foundation for Cancer Research ASPIRE Award.Research in the Nomura Research Group is focused on reimagining druggability using chemoproteomic platforms to discover new disease therapies. 
URL:https://scienceinboston.com/event/dana-farber-targeted-protein-degradation-seminar-dan-nomura/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201119T120000
DTEND;TZID=America/Vancouver:20201119T130000
DTSTAMP:20260413T020738
CREATED:20201103T214500Z
LAST-MODIFIED:20201103T214500Z
UID:27605-1605787200-1605790800@scienceinboston.com
SUMMARY:Dana Farber Targeted Protein Degradation Seminar: Dan Nomura
DESCRIPTION:Reimagining Druggability using Chemoproteomic Platforms\nWebinar registration: \nhttps://dfci.zoom.us/webinar/register/WN_IgnG5R2VSseCnikqf-v_1A \nHost: Breanna Zerfas \n\n\nDan Nomura\n\n\nDan Nomura is a professor in the Departments of Chemistry\, Molecular and Cell Biology\, and Nutritional Sciences and Toxicology at the University of California\, Berkeley. He is the director of the Novartis-Berkeley Center for Proteomics and Chemistry Technologies focused on using chemoproteomic platforms to tackle the undruggable proteome. Dr. Nomura is also the co-founder for Frontier Medicines. Dr. Nomura is an editor for Cell Chemical Biology. He earned his B.A. in Molecular and Cell Biology and Ph.D. in Molecular Toxicology with Professor John Casida at UC Berkeley and was a postdoctoral fellow at The Scripps Research Institute in chemical physiology with Professor Ben Cravatt before returning to UC Berkeley as a faculty member in 2011. Among his honors are selection as a Searle Scholar\, American Cancer Society Research Scholar Award\, and the Mark Foundation for Cancer Research ASPIRE Award.Research in the Nomura Research Group is focused on reimagining druggability using chemoproteomic platforms to discover new disease therapies. 
URL:https://scienceinboston.com/event/dana-farber-targeted-protein-degradation-seminar-dan-nomura-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201118T160000
DTEND;TZID=America/Vancouver:20201118T173000
DTSTAMP:20260413T020738
CREATED:20201022T210520Z
LAST-MODIFIED:20201022T210520Z
UID:11264-1605715200-1605720600@scienceinboston.com
SUMMARY:BU Research on Tap: Diverse Approaches to Understanding and Controlling COVID-19
DESCRIPTION:The COVID-19 pandemic erupted with unprecedented speed. There remains much we do not understand about COVID-19 and the pathogen responsible for causing it\, the novel coronavirus now known as SARS-CoV-2. Although this virus was initially thought to be solely respiratory\, we now know it is capable of causing a more widespread disease. Given the urgency to understand this pathogen and the disease it causes\, BU scientists from a variety of disciplines turned their attention to developing tools to understand the virus and its impact on the cell it infects\, identifying therapies to interfere with the viral life cycle\, developing models to study the disease process\, and developing novel means to detect and inactivate the virus. This session is intended to provide insights into the diverse challenges the SARS-CoV-2 virus presents\, and how BU scientists are responding to help control it.
URL:https://scienceinboston.com/event/bu-research-on-tap-diverse-approaches-to-understanding-and-controlling-covid-19/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201118T160000
DTEND;TZID=America/Vancouver:20201118T173000
DTSTAMP:20260413T020738
CREATED:20201022T210520Z
LAST-MODIFIED:20201022T210520Z
UID:27601-1605715200-1605720600@scienceinboston.com
SUMMARY:BU Research on Tap: Diverse Approaches to Understanding and Controlling COVID-19
DESCRIPTION:The COVID-19 pandemic erupted with unprecedented speed. There remains much we do not understand about COVID-19 and the pathogen responsible for causing it\, the novel coronavirus now known as SARS-CoV-2. Although this virus was initially thought to be solely respiratory\, we now know it is capable of causing a more widespread disease. Given the urgency to understand this pathogen and the disease it causes\, BU scientists from a variety of disciplines turned their attention to developing tools to understand the virus and its impact on the cell it infects\, identifying therapies to interfere with the viral life cycle\, developing models to study the disease process\, and developing novel means to detect and inactivate the virus. This session is intended to provide insights into the diverse challenges the SARS-CoV-2 virus presents\, and how BU scientists are responding to help control it.
URL:https://scienceinboston.com/event/bu-research-on-tap-diverse-approaches-to-understanding-and-controlling-covid-19-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201118T120000
DTEND;TZID=America/Vancouver:20201118T130000
DTSTAMP:20260413T020738
CREATED:20201030T155201Z
LAST-MODIFIED:20201030T155201Z
UID:11408-1605700800-1605704400@scienceinboston.com
SUMMARY:Webinar: Investigating Cellular Pathways Driving Severe COVID-19: Fresh Insights from Longitudinal Plasma Proteomics
DESCRIPTION:COVID-19 has caused more than 1 million deaths worldwide. Extraordinary research efforts are being made at the lab bench and in the clinic\, aided by initiatives such as diverted funding\, accelerated publication channels\, increased collaboration\, and open sharing of data. In order to accelerate research into the pandemic\, the “COVID-19 Technology Access Framework” was set up by Harvard University\, the Massachusetts Institute of Technology\, and Stanford University\, to pool resources and ensure that research findings and data are shared rapidly and openly to inform the public health response. Within this framework\, researchers from Massachusetts General Hospital recently collaborated with Olink Proteomics to carry out one of the largest longitudinal COVID-19 studies to date. This study aimed to generate new insights into the mechanisms underlying immune responses and disease severity in infected patients by serial measurements of over 1\,400 proteins in a cohort of ~400 SARS-CoV-2–infected patients and symptomatic controls. Hundreds of plasma proteins were found to be differentially expressed between COVID-19 patients and controls\, as well as between those with mild and severe forms of the disease. Together with cellular and RNA expression analyses\, the study also enabled a detailed dissection of both systemic and tissue-specific responses to SARS-CoV-2. This rich dataset of over 1.3 million protein measurements and essential clinical data has been made freely available to the scientific community to facilitate further investigation of pathways underlying severe disease—which may be the basis for early diagnosis of COVID-19 and subsequent clinical intervention. \nDuring the webinar\, viewers will: \n\nLearn how the levels of over 600 plasma proteins differ between infected patients and controls\, with a “viral response signature” of multiple cytokines and other proteins identified\nDiscover that more than 200 proteins also discriminate between severe and non-severe COVID-19\, and that specific proteins are associated with survival or death in those with severe disease\nHear about the differential molecular and cellular immune responses to SARS-CoV-2 infection at the tissue and systemic level\, and gain new insights into tissue-specific cell death signatures and cell-to-cell communication\nHave the opportunity to ask questions during the live broadcast.\n\nThis webinar will last for approximately 60 minutes. \nSpeaker bios\n\nMichael Filbin\, M.D.\, M.Sc.\n\nMassachusetts General Hospital\nBoston\, MA \n\nDr. Filbin is an emergency physician and director of clinical research in the Department of Emergency Medicine at Massachusetts General Hospital (MGH) in Boston and an associated member of the Broad Institute of MIT and Harvard. His research involves early detection and management of septic shock. Over the past decade\, Dr. Filbin has been a key investigator in U.S. National Institutes of Health–funded multicenter clinical trials\, led sepsis quality improvement efforts\, and investigated early sepsis detection strategies. He cochairs the Sepsis Early Detection Think Tank at MGH with the mission of joining translational researchers and clinical investigators within the Harvard community to encourage novel diagnostic and therapeutic approaches in sepsis. Dr. Filbin received a bachelor’s degree in aeronautics and aerospace engineering from the University of Washington in Seattle. He embarked on a career in engineering at the National Aeronautics and Space Administration in Houston\, Texas\, before attending medical school at Baylor College of Medicine in Houston. He completed a residency in emergency medicine at the combined Harvard Affiliated Emergency Medicine Residency program and received a Master’s in clinical epidemiology from the Harvard School of Public Health in Boston. \n\n\n\n\nArnav Mehta\, M.D.\, Ph.D.\n\nBroad Institute of MIT and Harvard\nBoston\, MA \n\nDr. Mehta is an oncologist\, immunologist\, and mathematician who is currently a postdoctoral researcher in Nir Hacohen and Eric Lander’s labs at the Broad Institute of MIT and Harvard\, and a clinical fellow in hematology/oncology at the Dana-Farber Cancer Institute/Partners CancerCare. Prior to his current position\, he obtained his undergraduate degrees at Duke University studying mathematics and chemistry\, his M.D. at the David Geffen School of Medicine at the University of California\, Los Angeles\, and his Ph.D. in biology and bioengineering at the California Institute of Technology under the guidance of Nobel laureate David Baltimore. He completed his internal medicine residency at Massachusetts General Hospital in the Stanbury Physician-Scientist Pathway program. His current interests lie at the intersection of tumor immunology and computational biology\, with a focus on building new tools for single-cell genomics studies in tumors. \n\n\n\n\nSean Sanders\, Ph.D.\n\nScience/AAAS\nWashington\, DC \n\nDr. Sanders did his undergraduate training at the University of Cape Town\, South Africa\, and his Ph.D. at the University of Cambridge\, UK\, supported by the Wellcome Trust. Following postdoctoral training at the National Institutes of Health and Georgetown University\, Dr. Sanders joined TranXenoGen\, a startup biotechnology company in Massachusetts working on avian transgenics. Pursuing his parallel passion for writing and editing\, Dr. Sanders joined BioTechniques as an editor\, before joining Science/AAAS in 2006. Currently\, Dr. Sanders is the Director and Senior Editor for Custom Publishing for the journal Science and Program Director for Outreach.
URL:https://scienceinboston.com/event/webinar-investigating-cellular-pathways-driving-severe-covid-19-fresh-insights-from-longitudinal-plasma-proteomics/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/10/ElAnxPUXgAEQXuJ.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201118T120000
DTEND;TZID=America/Vancouver:20201118T130000
DTSTAMP:20260413T020738
CREATED:20201030T155201Z
LAST-MODIFIED:20201030T155201Z
UID:27602-1605700800-1605704400@scienceinboston.com
SUMMARY:Webinar: Investigating Cellular Pathways Driving Severe COVID-19: Fresh Insights from Longitudinal Plasma Proteomics
DESCRIPTION:COVID-19 has caused more than 1 million deaths worldwide. Extraordinary research efforts are being made at the lab bench and in the clinic\, aided by initiatives such as diverted funding\, accelerated publication channels\, increased collaboration\, and open sharing of data. In order to accelerate research into the pandemic\, the “COVID-19 Technology Access Framework” was set up by Harvard University\, the Massachusetts Institute of Technology\, and Stanford University\, to pool resources and ensure that research findings and data are shared rapidly and openly to inform the public health response. Within this framework\, researchers from Massachusetts General Hospital recently collaborated with Olink Proteomics to carry out one of the largest longitudinal COVID-19 studies to date. This study aimed to generate new insights into the mechanisms underlying immune responses and disease severity in infected patients by serial measurements of over 1\,400 proteins in a cohort of ~400 SARS-CoV-2–infected patients and symptomatic controls. Hundreds of plasma proteins were found to be differentially expressed between COVID-19 patients and controls\, as well as between those with mild and severe forms of the disease. Together with cellular and RNA expression analyses\, the study also enabled a detailed dissection of both systemic and tissue-specific responses to SARS-CoV-2. This rich dataset of over 1.3 million protein measurements and essential clinical data has been made freely available to the scientific community to facilitate further investigation of pathways underlying severe disease—which may be the basis for early diagnosis of COVID-19 and subsequent clinical intervention. \nDuring the webinar\, viewers will: \n\nLearn how the levels of over 600 plasma proteins differ between infected patients and controls\, with a “viral response signature” of multiple cytokines and other proteins identified\nDiscover that more than 200 proteins also discriminate between severe and non-severe COVID-19\, and that specific proteins are associated with survival or death in those with severe disease\nHear about the differential molecular and cellular immune responses to SARS-CoV-2 infection at the tissue and systemic level\, and gain new insights into tissue-specific cell death signatures and cell-to-cell communication\nHave the opportunity to ask questions during the live broadcast.\n\nThis webinar will last for approximately 60 minutes. \nSpeaker bios\n\nMichael Filbin\, M.D.\, M.Sc.\n\nMassachusetts General Hospital\nBoston\, MA \n\nDr. Filbin is an emergency physician and director of clinical research in the Department of Emergency Medicine at Massachusetts General Hospital (MGH) in Boston and an associated member of the Broad Institute of MIT and Harvard. His research involves early detection and management of septic shock. Over the past decade\, Dr. Filbin has been a key investigator in U.S. National Institutes of Health–funded multicenter clinical trials\, led sepsis quality improvement efforts\, and investigated early sepsis detection strategies. He cochairs the Sepsis Early Detection Think Tank at MGH with the mission of joining translational researchers and clinical investigators within the Harvard community to encourage novel diagnostic and therapeutic approaches in sepsis. Dr. Filbin received a bachelor’s degree in aeronautics and aerospace engineering from the University of Washington in Seattle. He embarked on a career in engineering at the National Aeronautics and Space Administration in Houston\, Texas\, before attending medical school at Baylor College of Medicine in Houston. He completed a residency in emergency medicine at the combined Harvard Affiliated Emergency Medicine Residency program and received a Master’s in clinical epidemiology from the Harvard School of Public Health in Boston. \n\n\n\n\nArnav Mehta\, M.D.\, Ph.D.\n\nBroad Institute of MIT and Harvard\nBoston\, MA \n\nDr. Mehta is an oncologist\, immunologist\, and mathematician who is currently a postdoctoral researcher in Nir Hacohen and Eric Lander’s labs at the Broad Institute of MIT and Harvard\, and a clinical fellow in hematology/oncology at the Dana-Farber Cancer Institute/Partners CancerCare. Prior to his current position\, he obtained his undergraduate degrees at Duke University studying mathematics and chemistry\, his M.D. at the David Geffen School of Medicine at the University of California\, Los Angeles\, and his Ph.D. in biology and bioengineering at the California Institute of Technology under the guidance of Nobel laureate David Baltimore. He completed his internal medicine residency at Massachusetts General Hospital in the Stanbury Physician-Scientist Pathway program. His current interests lie at the intersection of tumor immunology and computational biology\, with a focus on building new tools for single-cell genomics studies in tumors. \n\n\n\n\nSean Sanders\, Ph.D.\n\nScience/AAAS\nWashington\, DC \n\nDr. Sanders did his undergraduate training at the University of Cape Town\, South Africa\, and his Ph.D. at the University of Cambridge\, UK\, supported by the Wellcome Trust. Following postdoctoral training at the National Institutes of Health and Georgetown University\, Dr. Sanders joined TranXenoGen\, a startup biotechnology company in Massachusetts working on avian transgenics. Pursuing his parallel passion for writing and editing\, Dr. Sanders joined BioTechniques as an editor\, before joining Science/AAAS in 2006. Currently\, Dr. Sanders is the Director and Senior Editor for Custom Publishing for the journal Science and Program Director for Outreach.
URL:https://scienceinboston.com/event/webinar-investigating-cellular-pathways-driving-severe-covid-19-fresh-insights-from-longitudinal-plasma-proteomics-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/10/ElAnxPUXgAEQXuJ.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201118T100000
DTEND;TZID=America/Vancouver:20201118T160000
DTSTAMP:20260413T020738
CREATED:20201022T205608Z
LAST-MODIFIED:20201022T205608Z
UID:11259-1605693600-1605715200@scienceinboston.com
SUMMARY:MIT Neurotech 2020
DESCRIPTION:The Neurotech 2020 symposium presents virtual talks by neurotechnology pioneers whose cutting-edge innovations are changing the face of neurobiological research from molecules to cognition. The symposium is open to the public\, but registration is required.  This year’s speakers are Todd Coleman (UCSD)\, Guosong Hong (Stanford University)\, Xin Jin (Harvard University & Broad Institute)\, Nancy Kopell (Boston University)\, Rosalind Picard (MIT)\, and Mikhail Shapiro (Caltech).  Talk schedule and registration link to follow soon.
URL:https://scienceinboston.com/event/mit-neurotech-2020/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/10/MIT-Neurotech-2020.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201118T100000
DTEND;TZID=America/Vancouver:20201118T160000
DTSTAMP:20260413T020738
CREATED:20201022T205608Z
LAST-MODIFIED:20201022T205608Z
UID:27600-1605693600-1605715200@scienceinboston.com
SUMMARY:MIT Neurotech 2020
DESCRIPTION:The Neurotech 2020 symposium presents virtual talks by neurotechnology pioneers whose cutting-edge innovations are changing the face of neurobiological research from molecules to cognition. The symposium is open to the public\, but registration is required.  This year’s speakers are Todd Coleman (UCSD)\, Guosong Hong (Stanford University)\, Xin Jin (Harvard University & Broad Institute)\, Nancy Kopell (Boston University)\, Rosalind Picard (MIT)\, and Mikhail Shapiro (Caltech).  Talk schedule and registration link to follow soon.
URL:https://scienceinboston.com/event/mit-neurotech-2020-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/10/MIT-Neurotech-2020.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201117T090000
DTEND;TZID=America/Vancouver:20201118T180000
DTSTAMP:20260413T020738
CREATED:20201014T183049Z
LAST-MODIFIED:20201014T183049Z
UID:11038-1605603600-1605722400@scienceinboston.com
SUMMARY:Future Labs Live USA 2020
DESCRIPTION:Future Labs USA 2020 (Nov 17-18) is America’s most exciting virtual event for scientific research professionals in everything from lab automation to site planning and data & analytics. Over the 2 days you’ll network with peers\, watch 15+ hours of live panel discussions and participate in your choice of virtual roundtable. Our 70+ expert speakers come from companies like Genentech\, Novartis\, 23andMe\, Biogen and Seattle Genetics. What’s more – it’s FREE! Sign up now to join the virtual conference on November 17 and 18 —> https://bit.ly/3lptOEj
URL:https://scienceinboston.com/event/future-labs-live-usa-2020/
LOCATION:NY
ATTACH;FMTTYPE=image/png:https://scienceinboston.com/wp-content/uploads/sites/6/2020/10/5468-Future-Labs-Live-USA-Logo-FINAL.png
ORGANIZER;CN="Terrapinn":MAILTO:bree.vaughn@terrapinn.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201117T090000
DTEND;TZID=America/Vancouver:20201118T180000
DTSTAMP:20260413T020738
CREATED:20201014T183049Z
LAST-MODIFIED:20201014T183049Z
UID:27593-1605603600-1605722400@scienceinboston.com
SUMMARY:Future Labs Live USA 2020
DESCRIPTION:Future Labs USA 2020 (Nov 17-18) is America’s most exciting virtual event for scientific research professionals in everything from lab automation to site planning and data & analytics. Over the 2 days you’ll network with peers\, watch 15+ hours of live panel discussions and participate in your choice of virtual roundtable. Our 70+ expert speakers come from companies like Genentech\, Novartis\, 23andMe\, Biogen and Seattle Genetics. What’s more – it’s FREE! Sign up now to join the virtual conference on November 17 and 18 —> https://bit.ly/3lptOEj
URL:https://scienceinboston.com/event/future-labs-live-usa-2020-2/
LOCATION:NY
ATTACH;FMTTYPE=image/png:https://scienceinboston.com/wp-content/uploads/sites/6/2020/10/5468-Future-Labs-Live-USA-Logo-FINAL.png
ORGANIZER;CN="Terrapinn":MAILTO:bree.vaughn@terrapinn.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201113T140000
DTEND;TZID=America/Vancouver:20201113T160000
DTSTAMP:20260413T020738
CREATED:20201106T170127Z
LAST-MODIFIED:20201106T171609Z
UID:11509-1605276000-1605283200@scienceinboston.com
SUMMARY:Stem Cell Day
DESCRIPTION:
URL:https://scienceinboston.com/event/stem-cell-day/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/11/Stem-cell-day-2020-min-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201113T140000
DTEND;TZID=America/Vancouver:20201113T160000
DTSTAMP:20260413T020738
CREATED:20201106T170127Z
LAST-MODIFIED:20201106T170127Z
UID:27607-1605276000-1605283200@scienceinboston.com
SUMMARY:Stem Cell Day
DESCRIPTION:
URL:https://scienceinboston.com/event/stem-cell-day-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/11/Stem-cell-day-2020-min-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201112T180000
DTEND;TZID=America/Vancouver:20201112T193000
DTSTAMP:20260413T020738
CREATED:20201009T193108Z
LAST-MODIFIED:20201110T195611Z
UID:10822-1605204000-1605209400@scienceinboston.com
SUMMARY:Beyond Academia: A Career Panel Discussion for Life Science PhDs
DESCRIPTION:Science in Boston invites you to attend a virtual career event exploring science careers outside of academia. The evening will feature keynote speaker Dr. Nicole Quinn\, Associate Director of Scientific Communications at STEMCELL Technologies\, who will discuss her career transition from academia to science communications\, and offer tangible advice for identifying and pursuing various careers outside of academic research. This will be followed by a panel discussion with industry experts\, who will share their experience and expertise in a myriad of career options.  \n\n\nDetails\n\nDate:\n November 12 \nTime:\n\n6:00 pm – 7:30 pm EST\n\n\nAdditional details will be confirmed via email the week of the event\n\n\nKeynote Speaker\n \n\nNicole Quinn\, PhD\nAssociate Director\, Scientific Communications\nSTEMCELL Technologies \n\n\nPanelists\n \n\nChristine Genge\, PhD\nManager\, Recruitment\nSTEMCELL Technologies \n\n\n \n\nMaria Genco\, PhD\nBusiness Development Analyst\nAddgene \n\n\n \n\nJoseph Yawe\, PhD\nManager\, Inside Sales\nSTEMCELL Technologies \n\n\n\n \n\nRicha Hanamsagar\, PhD\nSenior Scientist\nSanofi \n\n\n\n \n\nGaia Trincucci\, PhD\nScientific Editor\nJournal of Experimental Medicine \n\n\n\n \n\nJonathan Han\, PhD\nManager\, Scientific Marketing\nSTEMCELL Technologies \n\n\n\n\nRegistration\nWe are at capacity\, and registration for this event is now closed.
URL:https://scienceinboston.com/event/beyondacademia/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201112T180000
DTEND;TZID=America/Vancouver:20201112T193000
DTSTAMP:20260413T020738
CREATED:20201009T193108Z
LAST-MODIFIED:20201009T193108Z
UID:27589-1605204000-1605209400@scienceinboston.com
SUMMARY:Beyond Academia: A Career Panel Discussion for Life Science PhDs
DESCRIPTION:Science in Boston invites you to attend a virtual career event exploring science careers outside of academia. The evening will feature keynote speaker Dr. Nicole Quinn\, Associate Director of Scientific Communications at STEMCELL Technologies\, who will discuss her career transition from academia to science communications\, and offer tangible advice for identifying and pursuing various careers outside of academic research. This will be followed by a panel discussion with industry experts\, who will share their experience and expertise in a myriad of career options.  \n\n\nDetails\n\nDate:\n November 12 \nTime:\n\n6:00 pm – 7:30 pm EST\n\n\nAdditional details will be confirmed via email the week of the event\n\n\nKeynote Speaker\n \n\nNicole Quinn\, PhD\nAssociate Director\, Scientific Communications\nSTEMCELL Technologies \n\n\nPanelists\n \n\nChristine Genge\, PhD\nManager\, Recruitment\nSTEMCELL Technologies \n\n\n \n\nMaria Genco\, PhD\nBusiness Development Analyst\nAddgene \n\n\n \n\nJoseph Yawe\, PhD\nManager\, Inside Sales\nSTEMCELL Technologies \n\n\n\n \n\nRicha Hanamsagar\, PhD\nSenior Scientist\nSanofi \n\n\n\n \n\nGaia Trincucci\, PhD\nScientific Editor\nJournal of Experimental Medicine \n\n\n\n \n\nJonathan Han\, PhD\nManager\, Scientific Marketing\nSTEMCELL Technologies \n\n\n  input.ninja-forms-field{border-width: 1px;}\n.nf-field-label label{color: #777777;}\nselect.ninja-forms-field{color:#777777 ; background:white ;    font-size: 14px;    font-weight: normal;    background: #fff url(data:image/svg+xml;charset=US-ASCII\,%3Csvg%20width%3D%2220%22%20height%3D%2220%22%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%3E%3Cpath%20d%3D%22M5%206l5%205%205-5%202%201-7%207-7-7%202-1z%22%20fill%3D%22%23555%22%2F%3E%3C%2Fsvg%3E) no-repeat right 5px top 55%;\n    background-size: 16px 16px;\n    cursor: pointer;}\n.nf-field-element input\, .nf-field-element select\, .nf-field-element textarea {    border: 1px solid #C8C8C8;    padding: 5px;}\n.nf-before-form-content {    padding-bottom: 20px;}\n.tribe-events-single-section.tribe-events-event-meta.primary.tribe-clearfix {    display: none;}\n.tribe-events-single-section.tribe-events-event-meta.primary.tribe-clearfix.above-box {    display: block;}\nselect.ninja-forms-field:after{\n    font-family: “Font Awesome 5 Free”;\n    position: absolute;\n    visibility: visible;\n    font-family: FontAwesome;\n    content: “\f096”;\n    font-size: 18px;\n}\n} \n\nRegistration\nWe are at capacity\, and registration for this event is now closed.
URL:https://scienceinboston.com/event/beyondacademia-2/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201112T170000
DTEND;TZID=America/Vancouver:20201112T180000
DTSTAMP:20260413T020738
CREATED:20201022T202933Z
LAST-MODIFIED:20201022T202933Z
UID:11254-1605200400-1605204000@scienceinboston.com
SUMMARY:Story Slam: Tales from the Bench and Beyond
DESCRIPTION:Students\, postdocs and faculty share tales from the bench and beyond.
URL:https://scienceinboston.com/event/story-slam-tales-from-the-bench-and-beyond/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/10/Story-slam.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201112T170000
DTEND;TZID=America/Vancouver:20201112T180000
DTSTAMP:20260413T020738
CREATED:20201022T202933Z
LAST-MODIFIED:20201022T202933Z
UID:27599-1605200400-1605204000@scienceinboston.com
SUMMARY:Story Slam: Tales from the Bench and Beyond
DESCRIPTION:Students\, postdocs and faculty share tales from the bench and beyond.
URL:https://scienceinboston.com/event/story-slam-tales-from-the-bench-and-beyond-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/10/Story-slam.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201112T120000
DTEND;TZID=America/Vancouver:20201112T130000
DTSTAMP:20260413T020738
CREATED:20201103T214403Z
LAST-MODIFIED:20201103T214403Z
UID:11464-1605182400-1605186000@scienceinboston.com
SUMMARY:Dana Farber Targeted Protein Degradation Seminar: Alessio Ciulli
DESCRIPTION:How PROTAC degraders work and why the ternary complex matters\nWebinar registration: https://dfci.zoom.us/webinar/register/WN_UelaN-D_QkehTiI097fCTg \nHost: Katherine Donovan \nAlessio Ciulli holds the Personal Chair of Chemical Structural Biology at the School of Life Sciences\, University of Dundee. Dr Ciulli’s laboratory has made important contributions to selective chemical intervention on protein-protein interactions targets and to the development of proteolysis-targeting chimeric molecules (PROTACs) as a viable strategy for targeted protein degradation. Amongst his most significant discoveries are the fragment-based design of ligands for the E3 ligase von Hippel-Lindau (VHL)\, and their use to design one of the first VHL-based PROTACs: the BET degrader MZ1. Dr Ciulli’s Lab later illuminated fundamental insights into PROTACs’ mechanism of action\, solving the first crystal structure of a PROTAC ternary complex. Dr. Ciulli is also the scientific founder of Amphista therapeutics\, a company that develops new protein degradation platforms. \nBefore joining Dundee\, Dr Ciulli was a group leader at the University of Cambridge\, where he previously earned his PhD degree. \nAmongst his honours are the EFMC Prize for Young Medicinal Chemist in Academia\, the RSC Capps Green Zomaya Award in medicinal computational chemistry\, and election as Fellow of the Royal Society of Chemistry.
URL:https://scienceinboston.com/event/dana-farber-targeted-protein-degradation-seminar-alessio-ciulli/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201112T120000
DTEND;TZID=America/Vancouver:20201112T130000
DTSTAMP:20260413T020738
CREATED:20201103T214403Z
LAST-MODIFIED:20201103T214403Z
UID:27604-1605182400-1605186000@scienceinboston.com
SUMMARY:Dana Farber Targeted Protein Degradation Seminar: Alessio Ciulli
DESCRIPTION:How PROTAC degraders work and why the ternary complex matters\nWebinar registration: https://dfci.zoom.us/webinar/register/WN_UelaN-D_QkehTiI097fCTg \nHost: Katherine Donovan \nAlessio Ciulli holds the Personal Chair of Chemical Structural Biology at the School of Life Sciences\, University of Dundee. Dr Ciulli’s laboratory has made important contributions to selective chemical intervention on protein-protein interactions targets and to the development of proteolysis-targeting chimeric molecules (PROTACs) as a viable strategy for targeted protein degradation. Amongst his most significant discoveries are the fragment-based design of ligands for the E3 ligase von Hippel-Lindau (VHL)\, and their use to design one of the first VHL-based PROTACs: the BET degrader MZ1. Dr Ciulli’s Lab later illuminated fundamental insights into PROTACs’ mechanism of action\, solving the first crystal structure of a PROTAC ternary complex. Dr. Ciulli is also the scientific founder of Amphista therapeutics\, a company that develops new protein degradation platforms. \nBefore joining Dundee\, Dr Ciulli was a group leader at the University of Cambridge\, where he previously earned his PhD degree. \nAmongst his honours are the EFMC Prize for Young Medicinal Chemist in Academia\, the RSC Capps Green Zomaya Award in medicinal computational chemistry\, and election as Fellow of the Royal Society of Chemistry.
URL:https://scienceinboston.com/event/dana-farber-targeted-protein-degradation-seminar-alessio-ciulli-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201112T080000
DTEND;TZID=America/Vancouver:20201112T124500
DTSTAMP:20260413T020738
CREATED:20201014T201859Z
LAST-MODIFIED:20201014T201859Z
UID:11050-1605168000-1605185100@scienceinboston.com
SUMMARY:Virtual Discover Brigham 2020
DESCRIPTION:Discover Brigham is an annual event that provides the community with a firsthand look at the incredible action going on behind-the-scenes at Brigham and Women’s Hospital. This unique event showcases current projects and accomplishments of investigators who are paving the way for further discovery and innovation. This year\, we are reimagining Discover Brigham in light of COVID-19 and will be hosting it virtually. We are truly excited for this extraordinary opportunity to reach an even broader population of global citizens\, clinicians\, budding scientists and family members. \nTune in for six must-see sessions presented by Brigham researchers with topics ranging from artificial intelligence at the bedside and the COVID-19 research being conducted in our hospital to a competition among postdocs who will be pitching their research to the public in hopes of winning the $1\,000 prize. The conference will also feature virtually interactive demos and an extensive poster session with over 100 posters. \nWhether you are a fifth-grade student\, media influencer\, or experienced physician\, anyone with an interest in healthcare\, innovation\, or the expansive scope of scientific research\, will be captivated by this profound demonstration of investigative prowess. Mark your calendars\, take a seat on your favorite couch\, put your headphones on and get ready to immerse yourself in this hospital-wide event on November 12th! \n 
URL:https://scienceinboston.com/event/virtual-discover-brigham-2020/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/10/Virtual-Discover-Brigham-2020.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201112T080000
DTEND;TZID=America/Vancouver:20201112T124500
DTSTAMP:20260413T020738
CREATED:20201014T201859Z
LAST-MODIFIED:20201014T201859Z
UID:27595-1605168000-1605185100@scienceinboston.com
SUMMARY:Virtual Discover Brigham 2020
DESCRIPTION:Discover Brigham is an annual event that provides the community with a firsthand look at the incredible action going on behind-the-scenes at Brigham and Women’s Hospital. This unique event showcases current projects and accomplishments of investigators who are paving the way for further discovery and innovation. This year\, we are reimagining Discover Brigham in light of COVID-19 and will be hosting it virtually. We are truly excited for this extraordinary opportunity to reach an even broader population of global citizens\, clinicians\, budding scientists and family members. \nTune in for six must-see sessions presented by Brigham researchers with topics ranging from artificial intelligence at the bedside and the COVID-19 research being conducted in our hospital to a competition among postdocs who will be pitching their research to the public in hopes of winning the $1\,000 prize. The conference will also feature virtually interactive demos and an extensive poster session with over 100 posters. \nWhether you are a fifth-grade student\, media influencer\, or experienced physician\, anyone with an interest in healthcare\, innovation\, or the expansive scope of scientific research\, will be captivated by this profound demonstration of investigative prowess. Mark your calendars\, take a seat on your favorite couch\, put your headphones on and get ready to immerse yourself in this hospital-wide event on November 12th! \n 
URL:https://scienceinboston.com/event/virtual-discover-brigham-2020-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/10/Virtual-Discover-Brigham-2020.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201111T183000
DTEND;TZID=America/Vancouver:20201111T203000
DTSTAMP:20260413T020738
CREATED:20201103T214231Z
LAST-MODIFIED:20201103T214231Z
UID:11460-1605119400-1605126600@scienceinboston.com
SUMMARY:Antibiotics: From Cures to Crisis
DESCRIPTION:Time: 6:30-8:30 p.m.\, Wednesday\, November 11th \nJoin us on: Zoom or YouTube Live \nSpeakers: Molly Sargen \nGraphics: Iryna Stryapunina
URL:https://scienceinboston.com/event/antibiotics-from-cures-to-crisis/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinboston.com/wp-content/uploads/sites/6/2020/11/ANTIBIOTICS-FROM-CURES-TO-CRISIS.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201111T183000
DTEND;TZID=America/Vancouver:20201111T203000
DTSTAMP:20260413T020738
CREATED:20201103T214231Z
LAST-MODIFIED:20201103T214231Z
UID:27603-1605119400-1605126600@scienceinboston.com
SUMMARY:Antibiotics: From Cures to Crisis
DESCRIPTION:Time: 6:30-8:30 p.m.\, Wednesday\, November 11th \nJoin us on: Zoom or YouTube Live \nSpeakers: Molly Sargen \nGraphics: Iryna Stryapunina
URL:https://scienceinboston.com/event/antibiotics-from-cures-to-crisis-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinboston.com/wp-content/uploads/sites/6/2020/11/ANTIBIOTICS-FROM-CURES-TO-CRISIS.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201110T150000
DTEND;TZID=America/Vancouver:20201110T160000
DTSTAMP:20260413T020738
CREATED:20201022T202108Z
LAST-MODIFIED:20201022T202108Z
UID:11252-1605020400-1605024000@scienceinboston.com
SUMMARY:Amgen Biotech Seminar Series: Careers in Biotech
DESCRIPTION:This seminar is part of the Amgen Biotech Series and open to all BU students\, trainees\, and scholars. During this session\, we will discuss the current hiring trends in the biotech industry\, followed by a panel discussion\, introducing a diverse group of Amgen scientists.
URL:https://scienceinboston.com/event/amgen-biotech-seminar-series-careers-in-biotech/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20201110T150000
DTEND;TZID=America/Vancouver:20201110T160000
DTSTAMP:20260413T020738
CREATED:20201022T202108Z
LAST-MODIFIED:20201022T202108Z
UID:27598-1605020400-1605024000@scienceinboston.com
SUMMARY:Amgen Biotech Seminar Series: Careers in Biotech
DESCRIPTION:This seminar is part of the Amgen Biotech Series and open to all BU students\, trainees\, and scholars. During this session\, we will discuss the current hiring trends in the biotech industry\, followed by a panel discussion\, introducing a diverse group of Amgen scientists.
URL:https://scienceinboston.com/event/amgen-biotech-seminar-series-careers-in-biotech-2/
LOCATION:Online
END:VEVENT
END:VCALENDAR